Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115918 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alessandra Capuano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Proteomics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FARB 2022, PRIN2022-PNRR project, University of Salerno.
Abstract (Originalsprache)
This research focuses on the target deconvolution of the natural compound myrianthic acid, a triterpenoid characterized by an ursane skeleton isolated from the roots of Myrianthus arboreus and from Oenothera maritima Nutt. (Onagraceae), using MS-based chemical proteomic techniques. Application of drug affinity responsive target stability (DARTS) and targeted-limited proteolysis coupled to mass spectrometry (t-LiP-MS) led to the identification of the enzyme fatty acid synthase (FAS) as an interesting macromolecular counterpart of myrianthic acid. This result, confirmed by comparison with the natural ursolic acid, was thoroughly investigated and validated in silico by molecular docking, which gave a precise picture of the interactions in the MA/FAS complex. Moreover, biological assays showcased the inhibitory activity of myrianthic acid against the FAS enzyme, most likely related to its antiproliferative activity towards tumor cells. Given the significance of FAS in specific pathologies, especially cancer, the myrianthic acid structural moieties could serve as a promising reference point to start the potential development of innovative approaches in therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy.
- PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy.
- Department of Biosciences and Territory, University of Molise, C.da Fonte Lappone, 86090 Pesche, Italy.
- Department of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
- Biochem Lab, Department of Pharmacy, School of Medicine and Surgery, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.
ORCID-Profile: Gilda D'Urso, Gianluigi Lauro, Maria Grazia Ferraro, Carlo Irace, Agostino Casapullo
Förderung
- FARB 2022
- PRIN2022-PNRR project
- University of Salerno
- Ministero dell’Università e della Ricerca (MUR)
Zitieren
APA
Capuano, A., D'Urso, G., Gazzillo, E., Lauro, G., Chini, M. G., D'Auria, M. V., Ferraro, M. G., Iazzetti, F., Irace, C., Bifulco, G., & Casapullo, A. (2024). Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115918
Vancouver
Capuano A, D'Urso G, Gazzillo E, Lauro G, Chini MG, D'Auria MV, et al. Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115918
BibTeX
@article{Capuano2024,
author = {Capuano, Alessandra and D'Urso, Gilda and Gazzillo, Erica and Lauro, Gianluigi and Chini, Maria Giovanna and D'Auria, Maria Valeria and Ferraro, Maria Grazia and Iazzetti, Federica and Irace, Carlo and Bifulco, Giuseppe and Casapullo, Agostino},
title = {Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115918}
}
EUVIMED